Monthly Archives: February 2012

The pharmaceutical industry is helping state law enforcement officers track sales of a popular over-the-counter decongestant as part of a crackdown on “smurfing,” a way of collecting a key ingredient in the illegal drug methamphetamine. Authorities hope the industry-funded tracking … Continue reading →

Canada lacks oversight on online medical information, study finds Canada may have a state-run health-care system, but the federal government is noticeably reticent when it comes to providing medical information online. Wikipedia entries or pharmaceutical company websites are almost always … Continue reading →

NPS Pharmaceuticals to Present at Upcoming Health Care Conferences NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) will present at the Citi 2011 Global Health Care Conference in New York on Tuesday, March 1, 2011 at 10:30 a.m. ET and the Cowen and … Continue reading →

Global compliance issues influence pharmaceutical traceability Impending global legislation is set to bring wide-ranging changes to the coding and marking operations of pharmaceutical manufacturers. More challenges facing the healthcare industry today than at any time in the previous 30 years. … Continue reading →

Pharmaceutical Supply Chains Are Due for a Radical Overhaul Says PwC New Report Outlines Six Trends That Will Change the Way Drugs are Manufactured and Distributed NEW YORK, Feb. 21, 2011 /PRNewswire/ — While recent attention has focused on issues … Continue reading →

Incentives help pharmaceutical company to relocate to Piscataway When Innopharma Inc. ran out of space at its South Brunswick office, company officials began the search for a new home for the growing pharmaceutical and research company. “New Jersey is the … Continue reading →

Restricting FDI in pharma will be retrograde step: OPPI NEW DELHI: The Organisation of Pharmaceutical Producers of India (OPPI) today said any move to contain FDI in the pharma sector will be a “retrograde step”. Asserting that acquisition of domestic … Continue reading →

Success rates for experimental drugs falls: study NEW YORK (Reuters) – The success rate in bringing new medicines to market in recent years is only about half of what it had been previously, but biotech drugs are twice as likely … Continue reading →

Industry accepts decision not to raise drug prices The Health minister’s decision not to award any increase in the single exit price of drugs this year was in line with the agreed methodology and came as no surprise to the … Continue reading →

Drug Firms Must Swallow Bitter Pill It’s “crunch time” for the pharmaceutical sector and drug makers are worried sick. Representatives from the sector descended upon London this week to discuss the industry’s ailments. All were stunned by the bleak outlook. … Continue reading →